Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Terra Verde is a Portuguese medical cannabis company that was the first in the country to obtain a license for the cultivation of cannabis for medicinal purposes. The company focuses on the production of high-quality cannabis flower and derivatives for the European medical market, operating a state-of-the-art cultivation and processing facility. Following its acquisition by EMMAC Life Sciences (now part of Curaleaf International), Terra Verde serves as a key production hub within a larger vertically integrated European medical cannabis platform. Its operations are designed to meet stringent EU-GMP standards, ensuring pharmaceutical-grade products for patients across the continent.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Terra Verde.